Navigation Links
Experimental drug combination selectively destroys lymphoma cells
Date:2/6/2013

lls use for growth and survival. When ibrutinib was combined with bortezomib, the scientists observed a high level of synergism between the two drugs that resulted in profound cell death due to DNA damage, culminating in apoptosis. The research findings suggest that the effectiveness of the combination therapy against bortezomib-resistant lymphoma cells may stem from ibrutinib's ability to block signaling pathways used by the cancer cells to survive bortezomib exposure.

Specifically, exposure of DLBCL and MCL cells to ibrutinib blocked the cancer-promoting NF-κB, AKT and ERK1/2 signaling pathways. These signaling pathways provide cells with the ability to adapt to otherwise harmful environmental stimuli by transmitting messages from receptors located at the cell's surface to proteins within the cell that trigger a variety of biological processes. In particular, NF-κB, AKT and ERK1/2 have been shown to carry out many functions that allow cancer cells to survive and proliferate. Significantly, each of these pathways has been implicated in the development of resistance to proteasome inhibitors such as bortezomib.

"We have provided a framework for understanding how an agent like ibrutinib might be employed to enhance the activity of an established anti-cancer agent like bortezomib," says Grant. "We are currently working with representatives from the pharmaceutical industry and the National Cancer Institute to develop a new treatment strategy in which ibrutinib will be combined with proteasome inhibitors like bortezomib for the treatment of patients with lymphomas and potentially other blood cancers."


'/>"/>

Contact: John Wallace
wallacej@vcu.edu
804-628-1550
Virginia Commonwealth University
Source:Eurekalert  

0

GOOD

Page: 1 2

Related biology news :

1. Nicole George wins 2012 Journal of Experimental Biology Outstanding Paper Prize
2. FASEB SRC announces conference registration open for: Genetic Recombination & Genome Rearrangements
3. TGen, Scottsdale Healthcare study shows drug combination extends pancreatic cancer patient survival
4. Cats are able to navigate complex combinations of wet and dry foods to achieve a consistent intake of protein, fat and carbohydrate
5. Combination of two pharmaceuticals proves effective in the treatment of multiple sclerosis
6. Hormone combination effective and safe for treating obesity in mice
7. Insecticide resistance caused by recombination of 2 genes
8. New line of approach for combination therapy against melanoma
9. New study finds a protein combination is best to consume post-workout for building muscle
10. Research breakthrough selectively represses the immune system
11. New way to kill lymphoma without chemotherapy
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Experimental drug combination selectively destroys lymphoma cells
(Date:5/19/2013)... white men and women of European descent inherit common ... toe deformities, including hammer or claw toe. Findings from ... of foot disorders in humansappear in Arthritis Care ... behalf of the American College of Rheumatology (ACR). ... of older adults have foot disorders which may limit ...
(Date:5/19/2013)... at the University of California, Davis have engineered a ... for light. They report their findings today at ... Microbiology. , "In this work, we used synthetic biology ... carbon dioxide and light energy for growth) cyanobacterial metabolism ... Jordan McEwen, the lead researcher on the study. ...
(Date:5/18/2013)... (May 18, 2013) Research presented today at Digestive ... research, with findings about the impact of coffee on ... , While coffee consumption recently has been associated with ... even a few more cups of java each month ... liver disease. Researchers at the Mayo Clinic, Rochester, MN, ...
Breaking Biology News(10 mins):Blame your parents for bunion woes 2Coffee consumption associated with reduced risk of autoimmune liver disease 2
... complex feat of nanoengineering, a team of scientists at ... in creating a programable molecular transport system, the workings ... results, appearing in the latest issue of Nature ... advanced drug delivery methods and molecular manufacturing systems. ...
... Pharmaceuticals, illicit drugs, shampoo, toothpaste, pesticides, chemical run-off ... giant aquifer under Mexico,s "Riviera Maya," research shows. ... water-filled caves under the popular tourist destination on ... through the caves and into the Caribbean Sea. ...
... the days of Darwin, the "tree of life" has been ... gradual branching and changing of individual species. The discovery ... directly from one species of fungus to another, however, significantly ... mosaic, may be more appropriate. "The fungi are telling ...
Cached Biology News:Pollutants in aquifers may threaten future of Mexico's fast-growing 'Riviera Maya' 2Pollutants in aquifers may threaten future of Mexico's fast-growing 'Riviera Maya' 3Discovery of jumping gene cluster tangles tree of life 2Discovery of jumping gene cluster tangles tree of life 3
(Date:5/20/2013)... May 20, 2013 Pacific Biomarkers and Clinigene International ... developers of biosimilars at the 2013 AAPS/ National ... Diego Hotel and Marina , ... the opportunity to speak with company representatives at their ... Cross" on May 21 from 1-2 p.m. in the ...
(Date:5/20/2013)... BALTIMORE , May 20, 2013 /PRNewswire/ ... private-public partnership focusing on commercializing market-relevant biohealth innovations ... Central Maryland , today announced its ... first Entrepreneur-in-Residence (EIR) for BHI at the National ... and Blood Institute (NHLBI). Dr. Aiyar will ...
(Date:5/20/2013)... 2013   Flexion Therapeutics , Inc. today announced ... to its management team as chief financial officer. ... management experience with biotechnology and medical device companies. ... financial officer for Novavax (NASDAQ: NVAX ) ... $250 million through a combination of investment funding and ...
(Date:5/20/2013)... May 20, 2013 Interventional cardiologist Tony ... General Hospital (AGH) Cardiovascular Institute have helped pioneer ... artery disease (CAD) over the past three decades, ... balloon angioplasty and coronary artery stent implantation. , Today, ... play a prominent role in the study of a ...
Breaking Biology Technology:Pacific Biomarkers and Clinigene International To Announce Laboratory Solutions for Developers of Biosimilars at 2013 AAPS/ National Biotechnology Conference 2BioHealth Innovation, Inc. Names Ram Aiyar as Entrepreneur-in-Residence to NIH National Heart, Lung and Blood Institute 2BioHealth Innovation, Inc. Names Ram Aiyar as Entrepreneur-in-Residence to NIH National Heart, Lung and Blood Institute 3BioHealth Innovation, Inc. Names Ram Aiyar as Entrepreneur-in-Residence to NIH National Heart, Lung and Blood Institute 4Flexion Therapeutics Names Frederick Driscoll Chief Financial Officer 2Allegheny General Hospital Cardiovascular Institute Becomes Exclusive Pittsburgh Site for Study of Novel Coronary Artery Disease Device 2Allegheny General Hospital Cardiovascular Institute Becomes Exclusive Pittsburgh Site for Study of Novel Coronary Artery Disease Device 3Allegheny General Hospital Cardiovascular Institute Becomes Exclusive Pittsburgh Site for Study of Novel Coronary Artery Disease Device 4
... Cellectis (Alternext: ALCLS), the French genome engineering specialist, announces today ... Cellectis, approaches on vectors for meganucleases and genome surgery at the 13th ... held at the Marriott Wardman Park Hotel in Washington, USA , ... , , ...
... ,, TAIZHOU, China , ... Ltd.,one of the world,s leading biotechnology companies focusing on ... China Medical City (CMC) opened, China,s state-of-the-art stem ... Stem Cell Regenerative Medicine Industrial Project of,National Bio-Industry Base ...
... , , ... /PRNewswire-FirstCall/ - Quest PharmaTech Inc. (TSX-V: QPT) ("Quest" or the "Company"), ... cancer, today announced the dosing of the first patient under the ... in prostate cancer patients. The study will evaluate the localization, safety, ...
Cached Biology Technology:Cellectis to Present at the American Society of Gene & Cell Therapy Annual Meeting 2Beike Biotechnology Opens World's Largest Stem Cell Storage and Processing Facility 2Beike Biotechnology Opens World's Largest Stem Cell Storage and Processing Facility 3Beike Biotechnology Opens World's Largest Stem Cell Storage and Processing Facility 4Beike Biotechnology Opens World's Largest Stem Cell Storage and Processing Facility 5Quest PharmaTech Announces Dosing Of First Patient In Its Prostate Cancer Clinical Trial 2Quest PharmaTech Announces Dosing Of First Patient In Its Prostate Cancer Clinical Trial 3
Mouse monoclonal antibody raised against a partial recombinant CHD8. NCBI Entrez Gene ID = CHD8...
... raised against a partial recombinant ... TOPORS (NP_005793, 98 a.a. ... protein with GST tag. ... NM_005802 Protein ...
Mouse monoclonal antibody raised against a partial recombinant DENR. NCBI Entrez Gene ID = DENR...
Mouse monoclonal antibody raised against a full length recombinant SNAPC5. NCBI Entrez Gene ID = SNAPC5...
Biology Products: